Lanthanum cobaltite oxide, LaCoO3, was prepared by the evaporation technique and the amorphous metal complex method. Powders were characterized by X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron microscopy, and surface area measurements. The effect of the synthesis route on the phase purity, particle size, surface area, and morphology of the powders was studied. A single perovskite phase was synthesized at 700°C using the amorphous metal complex route. However, the evaporation technique required higher temperature for LaCoO3 crystallization. Based on the characterization results, low temperature formation of LaCoO3 was attributed to the homogeneity of the precursors. Such behavior also results in different microstructures. Powder synthesized by the amorphous metal complex method exhibited the highest surface area and the lowest particle size.
Single lanthanum ferrite phase was successfully prepared at low processing temperature using the polymerizable complex method. To implement this work, several techniques such as differential scanning calorimetry, X-ray diffraction, Fourier Transform Infrared Spectroscopy, scanning electron microscopy and BET surface area measurements were used. Throw the obtained results, it was shown that steps of preparing the powder precursor and temperature of its calcination are critical parameters for avoiding phase segregation and obtaining pure lanthanum ferrite compound. Thus, a single perovskite phase was obtained at 600 °C. At this temperature, the powder was found to be fine and homogeneous with an average crystallite size of 13 nm and a specific surface area of 12.5 m².g-1.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.